On the REPROCELL blog
Latest
What Are Off-Target Effects in Cellular Gene Editing? Risks, Detection, and Solutions
Explore off-target effects in gene editing, from CRISPR risks and AI-driven detection to genomic safety in iPSC therapies.
20 May 2026
%20(1).png?width=1000&height=562&name=New%20Approach%20Methodologies%20(NAMs)%20(1).png)
What to Look for in a Global Central Lab Partner for Clinical Trials
Selecting the right global central lab partner is crucial for clinical trial success, impacting data quality, logistics, and regulatory compliance.
14 May 2026
.jpg?width=1000&height=562&name=New%20Approach%20Methodologies%20(NAMs).jpg)
The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment
Explore how New Approach Methodologies are revolutionizing drug discovery and safety assessment by enhancing human-relevant research and reducing reliance on animal testing.
30 April 2026
.png?width=1000&height=562&name=New%20Approach%20Methodologies%20(NAMs).png)
Inside the Sample Lifecycle: How Central Labs Protect Data from Collection to Analysis
Explore how central laboratories safeguard data integrity throughout the sample lifecycle, from collection to analysis, ensuring reliable outcomes in research.
13 April 2026